• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描用 F-Flurpiridaz 进行静息/应激心肌灌注成像:在小鼠中的可行性研究。

Rest/stress myocardial perfusion imaging by positron emission tomography with F-Flurpiridaz: A feasibility study in mice.

机构信息

Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Center for Molecular Cardiology, University of Zurich, 8952, Schlieren, Switzerland.

出版信息

J Nucl Cardiol. 2023 Feb;30(1):62-73. doi: 10.1007/s12350-022-02968-9. Epub 2022 Apr 28.

DOI:10.1007/s12350-022-02968-9
PMID:35484467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984310/
Abstract

BACKGROUND

Myocardial perfusion imaging by positron emission tomography (PET-MPI) is the current gold standard for quantification of myocardial blood flow. F-flurpiridaz was recently introduced as a valid alternative to currently used PET-MPI probes. Nonetheless, optimum scan duration and time interval for image analysis are currently unknown. Further, it is unclear whether rest/stress PET-MPI with F-flurpiridaz is feasible in mice.

METHODS

Rest/stress PET-MPI was performed with F-flurpiridaz (0.6-3.0 MBq) in 27 mice aged 7-8 months. Regadenoson (0.1 µg/g) was used for induction of vasodilator stress. Kinetic modeling was performed using a metabolite-corrected arterial input function. Image-derived myocardial F-flurpiridaz uptake was assessed for different time intervals by placing a volume of interest in the left ventricular myocardium.

RESULTS

Tracer kinetics were best described by a two-tissue compartment model. K ranged from 6.7 to 20.0 mL·cm·min, while myocardial volumes of distribution (V) were between 34.6 and 83.6 mL·cm. Of note, myocardial F-flurpiridaz uptake (%ID/g) was significantly correlated with K at rest and following pharmacological vasodilation for all time intervals assessed. However, while Spearman's coefficients (r) ranged between 0.478 and 0.681, R values were generally low. In contrast, an excellent correlation of myocardial F-flurpiridaz uptake with V was obtained, particularly when employing the averaged myocardial uptake from 20 to 40 min post tracer injection (R ≥ 0.98). Notably, K and V were similarly sensitive to pharmacological vasodilation induction. Further, mean stress-to-rest ratios of K, V, and %ID/g F-flurpiridaz were virtually identical, suggesting that %ID/g F-flurpiridaz can be used to estimate coronary flow reserve (CFR) in mice.

CONCLUSION

Our findings suggest that a simplified assessment of relative myocardial perfusion and CFR, based on image-derived tracer uptake, is feasible with F-flurpiridaz in mice, enabling high-throughput mechanistic CFR studies in rodents.

摘要

背景

正电子发射断层扫描(PET-MPI)心肌灌注显像是目前量化心肌血流的金标准。F-氟比拉嗪最近被引入作为目前使用的 PET-MPI 探针的有效替代物。尽管如此,目前还不知道最佳的扫描持续时间和图像分析时间间隔。此外,尚不清楚 F-氟比拉嗪在小鼠中是否可行进行静息/应激 PET-MPI。

方法

在 27 只 7-8 月龄的小鼠中进行 F-氟比拉嗪(0.6-3.0 MBq)静息/应激 PET-MPI。使用雷加登素(0.1 µg/g)诱导血管扩张剂应激。使用校正代谢物的动脉输入函数进行动力学建模。通过在左心室心肌中放置感兴趣的体积,评估不同时间间隔的图像衍生的 F-氟比拉嗪摄取。

结果

示踪剂动力学最好用两室模型来描述。K 值范围为 6.7 至 20.0 mL·cm·min,而心肌分布容积(V)范围为 34.6 至 83.6 mL·cm。值得注意的是,在所有评估的时间间隔内,静息和药物扩张后的心肌 F-氟比拉嗪摄取(%ID/g)与 K 均呈显著相关。然而,尽管斯皮尔曼系数(r)范围在 0.478 到 0.681 之间,但 R 值通常较低。相比之下,获得了心肌 F-氟比拉嗪摄取与 V 的极好相关性,尤其是当使用注射示踪剂后 20 至 40 分钟的平均心肌摄取时(R ≥ 0.98)。值得注意的是,K 和 V 对药物诱导的血管扩张同样敏感。此外,K、V 和 F-氟比拉嗪摄取的平均应激/静息比值几乎相同,表明 F-氟比拉嗪摄取可用于估计小鼠的冠状动脉血流储备(CFR)。

结论

我们的研究结果表明,基于图像衍生示踪剂摄取,使用 F-氟比拉嗪在小鼠中进行相对心肌灌注和 CFR 的简化评估是可行的,从而能够在啮齿动物中进行高通量机制性 CFR 研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/e3e0b0bbefce/12350_2022_2968_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/63569bcde6e7/12350_2022_2968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/9bc47ec69edf/12350_2022_2968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/64bc76f8ceba/12350_2022_2968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/ec48a932934d/12350_2022_2968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/3e137717d7c4/12350_2022_2968_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/e3e0b0bbefce/12350_2022_2968_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/63569bcde6e7/12350_2022_2968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/9bc47ec69edf/12350_2022_2968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/64bc76f8ceba/12350_2022_2968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/ec48a932934d/12350_2022_2968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/3e137717d7c4/12350_2022_2968_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f1f/9984310/e3e0b0bbefce/12350_2022_2968_Fig6_HTML.jpg

相似文献

1
Rest/stress myocardial perfusion imaging by positron emission tomography with F-Flurpiridaz: A feasibility study in mice.正电子发射断层扫描用 F-Flurpiridaz 进行静息/应激心肌灌注成像:在小鼠中的可行性研究。
J Nucl Cardiol. 2023 Feb;30(1):62-73. doi: 10.1007/s12350-022-02968-9. Epub 2022 Apr 28.
2
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve.性激素在调节心肌灌注和冠状动脉血流储备中的作用。
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2209-2218. doi: 10.1007/s00259-022-05675-2. Epub 2022 Jan 13.
3
Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model.氟比洛芬 F 18 心肌血流储备的简化定量:在猪模型中与微球的验证。
J Nucl Med. 2011 Apr;52(4):617-24. doi: 10.2967/jnumed.110.083196.
4
Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in F-flurpiridaz positron emission tomography-myocardial perfusion imaging.用于心肌血流估计的自动运动校正可提高F-氟哌哒唑正电子发射断层扫描-心肌灌注成像中冠心病的诊断性能。
J Nucl Cardiol. 2025 Feb;44:102072. doi: 10.1016/j.nuclcard.2024.102072. Epub 2024 Nov 6.
5
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.氟吡咯烷 F-18 PET 心肌灌注显像在疑似冠心病患者中的应用。
J Am Coll Cardiol. 2023 Oct 17;82(16):1598-1610. doi: 10.1016/j.jacc.2023.08.016.
6
Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.用于检测冠状动脉疾病的氟比拉嗪 F18 正电子发射断层扫描:与单光子发射计算机断层心肌灌注成像的 II 期安全性和临床比较。
J Am Coll Cardiol. 2013 Jan 29;61(4):469-477. doi: 10.1016/j.jacc.2012.11.022. Epub 2012 Dec 19.
7
Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.氟[18F]氟吡拉赞正电子发射断层扫描评估冠状动脉疾病的 III 期临床试验。
J Am Coll Cardiol. 2020 Jul 28;76(4):391-401. doi: 10.1016/j.jacc.2020.05.063.
8
Impact of motion and partial volume effects correction on PET myocardial perfusion imaging using simultaneous PET-MR.运动和部分容积效应校正对使用同步正电子发射断层显像-磁共振成像(PET-MR)的PET心肌灌注成像的影响。
Phys Med Biol. 2017 Jan 21;62(2):326-343. doi: 10.1088/1361-6560/aa5087. Epub 2016 Dec 20.
9
Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction.用于患者运动检测和校正的动态静息(82)Rb 和氟比拉嗪 F 18 心肌灌注 PET 数据的自动三维配准。
Med Phys. 2011 Nov;38(11):6313-26. doi: 10.1118/1.3656951.
10
A US payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease.一项关于氟吡达唑正电子发射断层心肌灌注显像(Flurpiridaz-PET-MPI)与单光子发射计算机断层心肌灌注显像(SPECT-MPI)相比用于冠心病诊断的美国医保支付者预算影响分析。
J Med Econ. 2024 Jan-Dec;27(1):1542-1551. doi: 10.1080/13696998.2024.2431413. Epub 2024 Dec 3.

引用本文的文献

1
Age- and sex-specific differences in myocardial sympathetic tone and left ventricular remodeling following myocardial injury.心肌损伤后心肌交感神经张力及左心室重构的年龄和性别特异性差异。
Biol Sex Differ. 2025 Jan 16;16(1):2. doi: 10.1186/s13293-024-00673-5.
2
Comparative evaluation of a novel [F] F-Labeled PET tracer XTR004 against [N] ammonia in myocardial perfusion imaging for coronary artery disease.新型[F]F标记的PET示踪剂XTR004与[N]氨用于冠状动脉疾病心肌灌注成像的比较评估
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1864-1877. doi: 10.1007/s00259-024-07004-1. Epub 2024 Dec 17.
3
Progress of F-flurpiridaz in Clinical Trials.

本文引用的文献

1
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.冠状动脉血流储备与心血管结局:系统评价和荟萃分析。
Eur Heart J. 2022 Apr 19;43(16):1582-1593. doi: 10.1093/eurheartj/ehab775.
2
Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.评估疑似冠状动脉疾病患者的心肌灌注:氟吡达唑(F-18)注射液用于正电子发射断层扫描(PET)成像的第二项3期开放标签多中心研究的原理与设计。
J Nucl Cardiol. 2021 Jun;28(3):1105-1116. doi: 10.1007/s12350-021-02527-8. Epub 2021 Jan 31.
3
F-氟吡哒唑的临床试验进展。
Ann Nucl Cardiol. 2023;9(1):91-93. doi: 10.17996/anc.23-00011. Epub 2023 Oct 31.
4
Translational molecular imaging and drug development in Parkinson's disease.帕金森病的转化分子影像学与药物研发。
Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z.
5
Recent Advances in Cardiovascular Diseases Research Using Animal Models and PET Radioisotope Tracers.心血管疾病研究中使用动物模型和正电子发射断层扫描放射性示踪剂的最新进展。
Int J Mol Sci. 2022 Dec 26;24(1):353. doi: 10.3390/ijms24010353.
6
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve.性激素在调节心肌灌注和冠状动脉血流储备中的作用。
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2209-2218. doi: 10.1007/s00259-022-05675-2. Epub 2022 Jan 13.
Automation in Nuclear Cardiology: Time for Flurpiridaz to Join the Club.
核心脏病学中的自动化:氟吡哒嗪加入该领域的时候到了。
J Nucl Cardiol. 2022 Apr;29(2):709-711. doi: 10.1007/s12350-020-02421-9. Epub 2020 Nov 17.
4
[C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [F]LMI1195 uptake is NET-independent.[C]mHED PET在小鼠心肌中遵循双组织室模型,具有去甲肾上腺素转运体(NET)依赖性摄取,而[F]LMI1195摄取不依赖于NET。
EJNMMI Res. 2020 Sep 29;10(1):114. doi: 10.1186/s13550-020-00700-7.
5
Development, diagnostic performance, and interobserver agreement of a F-flurpiridaz PET automated perfusion quantitation system.F-氟吡拉达 PET 自动灌注定量系统的开发、诊断性能和观察者间一致性。
J Nucl Cardiol. 2022 Apr;29(2):698-708. doi: 10.1007/s12350-020-02335-6. Epub 2020 Sep 7.
6
Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.氟[18F]氟吡拉赞正电子发射断层扫描评估冠状动脉疾病的 III 期临床试验。
J Am Coll Cardiol. 2020 Jul 28;76(4):391-401. doi: 10.1016/j.jacc.2020.05.063.
7
[ F]Flurpiridaz: Facile and Improved Precursor Synthesis for this Next-Generation Cardiac Positron Emission Tomography Imaging Agent.氟吡拉达:这种下一代心脏正电子发射断层成像造影剂的简便改进前体合成。
ChemMedChem. 2020 Jun 17;15(12):1040-1043. doi: 10.1002/cmdc.202000085. Epub 2020 May 5.
8
Added value of myocardial blood flow using F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial.使用 F-氟比拉嗪 PET 评估心肌血流对诊断冠状动脉疾病的附加值:氟比拉嗪 301 试验。
J Nucl Cardiol. 2021 Oct;28(5):2313-2329. doi: 10.1007/s12350-020-02034-2. Epub 2020 Jan 30.
9
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
10
Will F flurpiridaz replace rubidium as the most commonly used perfusion tracer for PET myocardial perfusion imaging?氟吡达唑会取代铷成为正电子发射断层扫描(PET)心肌灌注成像中最常用的灌注示踪剂吗?
J Nucl Cardiol. 2019 Dec;26(6):2031-2033. doi: 10.1007/s12350-017-1153-z. Epub 2018 Nov 28.